Neurocrine Biosciences Inc

LTS:0K6R (USA)   Ordinary Shares
$ 136.60 (+0.3%) Dec 24
36.84
P/B:
5.12
Market Cap:
$ 13.87B
Enterprise V:
$ 12.89B
Volume:
221.00
Avg Vol (2M):
1.37K
Trade In:
Volume:
221.00
Avg Vol (2M):
1.37K

Business Description

Neurocrine Biosciences Inc
NAICS : 325414 SIC : 2836
ISIN : US64125C1099

Share Class Description:

LTS:0K6R: Ordinary Shares
Description
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt 4.89
Equity-to-Asset 0.77
Debt-to-Equity 0.09
Debt-to-EBITDA 0.44
Interest Coverage 4.18
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.97
Distress
Grey
Safe
Beneish M-Score -2.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.7
9-Day RSI 67.97
14-Day RSI 66.18
6-1 Month Momentum % -7.27
12-1 Month Momentum % -3.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.37
Quick Ratio 4.26
Cash Ratio 2.86
Days Inventory 423.49
Days Sales Outstanding 73.47
Days Payable 1083.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8
Shareholder Yield % -0.68

Financials (Next Earnings Date:2025-02-07 Est.)

LTS:0K6R's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Neurocrine Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,242.8
EPS (TTM) ($) 3.73
Beta 0.34
Volatility % 25.75
14-Day RSI 66.18
14-Day ATR ($) 3.26721
20-Day SMA ($) 129.808
12-1 Month Momentum % -3.32
52-Week Range ($) 110.99 - 157.8
Shares Outstanding (Mil) 101.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neurocrine Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Neurocrine Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Neurocrine Biosciences Inc Frequently Asked Questions

What is Neurocrine Biosciences Inc(LTS:0K6R)'s stock price today?
The current price of LTS:0K6R is $136.60. The 52 week high of LTS:0K6R is $157.80 and 52 week low is $110.99.
When is next earnings date of Neurocrine Biosciences Inc(LTS:0K6R)?
The next earnings date of Neurocrine Biosciences Inc(LTS:0K6R) is 2025-02-07 Est..
Does Neurocrine Biosciences Inc(LTS:0K6R) pay dividends? If so, how much?
Neurocrine Biosciences Inc(LTS:0K6R) does not pay dividend.

Press Release

Subject Date
No Press Release